STAT+: Nobel-winning optogenetics research has led to experimental treatments for blindness and Alzheimer’s
Summary
Optogenetics, which uses light to control genetically modified neurons, has become a foundational tool for studying how the brain works. Research built on the Nobel-winning technique is now supporting experimental treatments for blindness and Alzheimer’s disease.
The key shift is from using optogenetics primarily to map neural circuits to testing it
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A method that transformed basic brain research is moving toward clinical use, where its promise will be tested against the harder constraints of human medicine.